Phenytoin decreased QT interval duration in left ventricular rabbit wedge preparations compared with no drug. In HEK-293 cells stably transfected with hNaV1.5 cDNA, its INa IC50 was 49 000 nM. In hiPS-CMs (Cor 4U), Phenytoin produced negligible changes in CTD90 compared with no drug. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Phenytoin decreases QT interval in rabbit ventricular wedge preparations
Cell-based study · left ventricular rabbit wedge preparations [1]
In left ventricular rabbit wedge preparations, Phenytoin decreased QT interval duration compared with no drug.
Literature-Reported Treatment Conditions
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations
Compound reported in the paper: Phenytoin
The paper names Phenytoin without stating the salt or form; not verified as the sodium form supplied as A10722. No dose conversion or lot validation.
Materials and methods > Experimental drug assays (S47, S48); Results > In silico drug assays are in agreement with rabbit wedge and hiPs-CM experimental recordings (S122); Figure 5 legend (S155)
QT interval duration: QT interval duration; comparator: no drug — Materials and methods > Experimental drug assays (S48); Results > In silico drug assays are in agreement with rabbit wedge and hiPs-CM experimental recordings (S122)
Phenytoin inhibition of INa in transfected cells
Cell-based study · HEK-293 cells stably transfected with hNaV1.5 cDNA [2]
In HEK-293 cells stably transfected with hNaV1.5 cDNA, Phenytoin had an INa IC50 of 49 000 nM.
Literature-Reported Treatment Conditions
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle, control.
Methods and source locations
Compound reported in the paper: Phenytoin
The paper names Phenytoin without stating the salt or form; not verified as the sodium form supplied as A10722. No dose conversion or lot validation.
Methods > IC50 and EFTPC values (S9, S12); Table 1 legend (S120); Table 1 (T1.h1, T1.r19)
INa IC50 values: INa IC50 values — Methods > IC50 and EFTPC values (S12); Table 1 legend (S120); Table 1 (T1.h1, T1.r19)
Phenytoin produces negligible changes in cardiomyocyte duration readout
Cell-based study · hiPS-CMs (Cor 4U) [1]
In hiPS-CMs (Cor 4U), Phenytoin produced negligible changes in CTD90 compared with no drug.
Literature-Reported Treatment Conditions
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations
Compound reported in the paper: Phenytoin
The paper names Phenytoin without stating the salt or form; not verified as the sodium form supplied as A10722. No dose conversion or lot validation.
Materials and methods > Experimental drug assays (S49, S51); Results > In silico drug assays are in agreement with rabbit wedge and hiPs-CM experimental recordings (S122); Figure 5 legend (S155)
duration at 90% of the initial base value (CTD90): duration at 90% of the initial base value (CTD90); comparator: no drug — Materials and methods > Experimental drug assays (S51); Results > In silico drug assays are in agreement with rabbit wedge and hiPs-CM experimental recordings (S122)